These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34386698)

  • 1. Cardiovascular Magnetic Resonance Reveals Cardiac Pathophysiology in Autoimmune Rheumatic Diseases.
    Markousis-Mavrogenis G; Sfikakis PP; Koutsogeorgopoulou L; Dimitroulas T; Katsifis G; Giannakopoulou A; Voulgari P; Kolovou G; Kitas GD; Mavrogeni SI
    Mediterr J Rheumatol; 2021 Mar; 32(1):15-20. PubMed ID: 34386698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Magnetic Resonance as Pathophysiologic Tool in Diabetes Mellitus.
    Mavrogeni SI; Bacopoulou F; Markousis-Mavrogenis G; Giannakopoulou A; Kariki O; Vartela V; Kolovou G; Charmandari E; Chrousos G
    Front Endocrinol (Lausanne); 2021; 12():672302. PubMed ID: 34194393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction.
    Mavrogeni SI; Sfikakis PP; Markousis-Mavrogenis G; Bournia VK; Poulos G; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Katsifis G; Boki K; Vartela V; Kolovou G; Theodorakis G; Kitas GD
    Int J Cardiol; 2019 Jun; 284():105-109. PubMed ID: 30404725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
    Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1048-1058. PubMed ID: 24011774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connection between the heart and the gut.
    Berlot B; Harries I; Bucciarelli-Ducci C
    Heart; 2019 Aug; 105(15):1148-1196. PubMed ID: 30962193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular Tachycardia Has Mainly Non-Ischaemic Substrates in Patients with Autoimmune Rheumatic Diseases and a Preserved Ejection Fraction.
    Markousis-Mavrogenis G; Poulos G; Dimitroulas T; Giannakopoulou A; Mavragani C; Vartela V; Manolopoulou D; Kolovou G; Voulgari P; Sfikakis PP; Kitas GD; Mavrogeni SI
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33804066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance imaging in myocardial inflammation in autoimmune rheumatic diseases: An appraisal of the diagnostic strengths and limitations of the Lake Louise criteria.
    Mavrogeni S; Schwitter J; van Rossum A; Nijveldt R; Aletras A; Kolovou G; Pohost G; Lima J
    Int J Cardiol; 2018 Feb; 252():216-219. PubMed ID: 29153657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession.
    Kumar A; Beohar N; Arumana JM; Larose E; Li D; Friedrich MG; Dharmakumar R
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1265-73. PubMed ID: 22172783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-sestamibi SPECT.
    Langhans B; Nadjiri J; Jähnichen C; Kastrati A; Martinoff S; Hadamitzky M
    Int J Cardiovasc Imaging; 2014 Oct; 30(7):1357-63. PubMed ID: 24984612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging.
    Radunski UK; Lund GK; Stehning C; Schnackenburg B; Bohnen S; Adam G; Blankenberg S; Muellerleile K
    JACC Cardiovasc Imaging; 2014 Jul; 7(7):667-75. PubMed ID: 24954462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and imaging of heart failure in women with autoimmune rheumatic diseases.
    Mavrogeni SI; Markousis-Mavrogenis G; Koutsogeorgopoulou L; Dimitroulas T; Vartela V; Rigopoulos A; Noutsias M; Kolovou G
    Heart Fail Rev; 2019 Jul; 24(4):489-498. PubMed ID: 30830518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
    Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
    Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of dark-blood T2-weighted CMR for evaluation of acute myocardial injury.
    Srichai MB; Lim RP; Lath N; Babb J; Axel L; Kim D
    Invest Radiol; 2013 Jan; 48(1):24-31. PubMed ID: 23192160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac magnetic resonance including parametric mapping in acute Takotsubo syndrome: Preliminary findings.
    Dabir D; Luetkens J; Kuetting DLR; Feisst A; Isaak A; Schild HH; Thomas D
    Eur J Radiol; 2019 Apr; 113():217-224. PubMed ID: 30927950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: A cardiovascular magnetic resonance study with cold pressor test.
    Galea N; Rosato E; Gigante A; Borrazzo C; Fiorelli A; Barchetti G; Trombetta AC; Digiulio MA; Francone M; Catalano C; Carbone I
    PLoS One; 2020; 15(12):e0244282. PubMed ID: 33351821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of contrast enhanced cine steady-state free precession and T2-weighted CMR for assessment of ischemic myocardial area-at-risk in the presence of reperfusion injury.
    Hansen ESS; Pedersen SF; Pedersen SB; Bøtker HE; Kim WY
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1039-1045. PubMed ID: 30852704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction.
    Nordlund D; Klug G; Heiberg E; Koul S; Larsen TH; Hoffmann P; Metzler B; Erlinge D; Atar D; Aletras AH; Carlsson M; Engblom H; Arheden H
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):744-53. PubMed ID: 27002140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Cardiac Involvement in Amyloid A Amyloidosis by Cardiovascular Magnetic Resonance Imaging.
    Chamling B; Drakos S; Bietenbeck M; Klingel K; Meier C; Yilmaz A
    Front Cardiovasc Med; 2021; 8():757642. PubMed ID: 34646875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.